Charlie Rose has a series of interviews, one with Navigenics' David Agus, Dean Ornish, and George Church, and another with Francis Collins. In the first, they talk about personalized medicine, personal genomics, and what people should understand and be aware of. "Initially, people should keep their expectations low," says Church, but Agus, who went on Lipitor as a prophylactic against his 80 percent increased risk of having a heart attack, thinks that "this is a very important way of understanding the genetics of disease." In another interview, Rose chats with Francis Collins about what's next for him -- he officially leaves his post at NHGRI today -- and for genetic research.